Completed PHASE2 INTERVENTIONAL 3-arm NCT00914368

Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis (TOPAS-1)

TOPAS-1, A Pharmacodynamic Phase II Study of Clopidogrel P2Y12 Platelet Inhibition

Sponsor: Uppsala University

Conditions Acute Coronary Syndrome Coronary Artery Disease Heart Diseases Myocardial Infarction Stent Thrombosis

Interventions Clopidogrel

Updated 5 times since 2017 Last updated: Apr 12, 2010 Started: Jan 31, 2009 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Acute Coronary Syndrome and Coronary Artery Disease, this trial is completed. The trial is conducted by Uppsala University and has accumulated 5 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Uppsala University

Data source: Uppsala University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Uppsala, Sweden